ArticleBioMed research international2014

Lenalidomide induces immunomodulation in chronic lymphocytic leukemia and enhances antitumor immune responses mediated by NK and CD4 T cells.

Andrea Acebes-Huerta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.